Yanan Zhang

Identity

·  Professor

·  Doctoral Supervisor  

Education

·  2021.09–2026.06: Doctor of Veterinary Medicine (combined Master‑PhD program), Zhejiang University, Hangzhou, China.

·  2016.09–2021.06: Bachelor of Veterinary Medicine, Northeast Agricultural University, Harbin, China.

Professional Experience

·  2026.08–present: Professor, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China.

Research Interests

·  Animal microecology, with a focus on gut infection and inflammation‑related microbiomics. Current research investigates the molecular mechanisms by which gut microbiota‑derived metabolites regulate intestinal mucosal barrier homeostasis in the host.

Academic/Professional Affiliations

·  Member, Veterinary Public Health Branch, Chinese Association of Animal Science and Veterinary Medicine (CAAV) (2024.09–present).

·  Reviewer for Nature Communications, Animal Diseases, and other journals.

Awards and Honor

·  Outstanding Graduate of Zhejiang Province, Department of Education of Zhejiang Province (2026).

·  Outstanding Young Veterinary Talent, China Agricultural Science and Education Foundation (2024).

·  National Graduate Scholarship, Ministry of Education of China (2024).

·  Best Paper Award, 13th Yangtze River Delta Preventive Veterinary Medicine Doctoral Forum (2024).

·  “Three‑Good Student” of Heilongjiang Province, Department of Education of Heilongjiang Province (2019).

Research Grants

·  2027.01–2029.12: National Natural Science Foundation of China – Young Scientists Fund (Category C), continued funding, ongoing, Principal Investigator.

·  2026.08–2031.08: Talent Introduction Program of Sichuan Agricultural University, ongoing, Principal Investigator.

·  2025.01–2026.06: Doctoral Special Program, Young Elite Scientist Sponsorship Program by CAST, completed, Principal Investigator.

·  2024.05–2025.12: National Natural Science Foundation of China – Basic Research Project for Young Students (Doctoral Candidate), completed with “Excellent” evaluation, Principal Investigator.

Books and Monographs

·  Editorial Board Member, Animal Histology and Embryology (China Agricultural University Press), a national "13th Five-Year Plan" textbook.

Selected Publications

·  Jin-Xin Meng, Wen-Di Li, Wei-Fu Tao, Shuyu Tu, Jinsong Gao, Xinya Zhao, Jialei Li, Jianan Wu, Chang Liu, Yanan Zhang*, Shu Jeffrey Zhu*；An atlas of colonization factors in the human gut microbiome reveals ecological strategies and inflammatory bowel disease signatures, Nature Communications, 2026, DOI：10.1038/s41467-026-76763-2. (IF₅=18.9)

·  Yanan Zhang; Shuyu Tu; Xingwei Ji; Jianan Wu; Jinxin Meng; Jinsong Gao; Xian Shao; Shuai Shi; Gan Wang; Jingjing Qiu; Zhuobiao Zhang; Chengang Hua; Ziyi Zhang; Shuxian Chen; Li Zhang; Shu Jeffrey Zhu*; Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway, Nature Communications, 2024, 15(1333): 1-19. (IF₅=18.9, ESI Highly Cited/Hot Paper, top 0.1% in Immunology, cited 316 times)

·  Yanan Zhang^#; Shuyu Tu^#; Xian Shao^#; Jinxin Meng^#; Zhuobiao Zhang; Wei Wei; Xuping Jing; Zhewen Qin; Jianan Wu; Weilv Xu; Bofei Dong; Jinsong Gao; Aijuan Qu; Shuxian Chen; Li Zhang; Peng Gong; Bo Shan; Hui Shi; Shu Jeffrey Zhu*; Microbiota-derived IPA protects against colitis by regulating intestinal HMGCS2-mediated ketogenesis to facilitate mucosal healing through PPARα, Nature Communications, 2026;17(1):2437. (IF₅=18.9)

· Yanan Zhang^#; Jinxin Meng^#; Shuyu Tu^#; Linlin Ma^#; Xinya Zhao; Jinsong Gao; Jianan Wu; Weilv Xu; Shuxian Chen; Hairong Cheng; Li Zhang; Shu Jeffrey Zhu*; A microbiota-IPA axis facilitates intestinal stem cell-mediated regeneration in colitis through a Hopx-associated program, Nature Communications, 2026;17(1):3196. (IF₅=18.9)

· Yanan Zhang; Shu Jeffrey Zhu*; Role of bile acid metabolites in regulating viral infections, Trends in Microbiology, 2025, 34(2): 134-137. (IF₅=18.3)

·  Zhang Y, Zhao X, Wang H, et al. Integrating host-microbiota metabolic networks: how aromatic amino acids shape immune homeostasis and affect disease progression. Cellular & Molecular Immunologyl. 2026;23(7):773-786. (IF₅=27.60)